<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36738922</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2173-5794</ISSN><JournalIssue CitedMedium="Internet"><Volume>98</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Archivos de la Sociedad Espanola de Oftalmologia</Title><ISOAbbreviation>Arch Soc Esp Oftalmol (Engl Ed)</ISOAbbreviation></Journal><ArticleTitle>Bilateral neuroretinitis and membranous lupus nephritis: 2 infrequent manifestations in juvenile lupus.</ArticleTitle><Pagination><StartPage>175</StartPage><EndPage>179</EndPage><MedlinePgn>175-179</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.oftale.2023.01.002</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2173-5794(23)00009-9</ELocationID><Abstract><AbstractText>Fifteen-year-old female patient, previously healthy, referred to our center for presenting abdominal pain, vomiting, diarrhea, malar erythema, palpebral and lower limb edema, arthralgia, morning stiffness and bilateral blurred vision. Laboratory and imaging studies together with the clinic allowed the diagnosis of nephrotic syndrome secondary to systemic lupus erythematosus. Ophthalmology examination revealed a visual acuity of 8/10 in both eyes and bilateral disc edema with partial macular star, findings compatible with bilateral neuroretinitis. Renal biopsy established the diagnosis of membranous lupus nephritis. Immunosuppressive treatment was started, obtaining gradual clinical improvement. Although systemic lupus erythematosus with membranous lupus nephritis and neuroretinitis is a very infrequent association, when faced with a patient with bilateral neuroretinitis, we must consider systemic lupus erythematosus within the differential diagnoses.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Sociedad Espa&#xf1;ola de Oftalmolog&#xed;a. Published by Elsevier Espa&#xf1;a, S.L.U. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dorronsoro</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Servicio de Oftalmolog&#xed;a, Hospital Interzonal General Dr. Jos&#xe9; Penna, Bah&#xed;a Blanca, Buenos Aires, Argentina. Electronic address: marianeladorronsoro@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bronfen</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Servicio de Nefrolog&#xed;a Infantil, Hospital Interzonal General Dr. Jos&#xe9; Penna, Bah&#xed;a Blanca, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alconcher</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Servicio de Nefrolog&#xed;a Infantil, Hospital Interzonal General Dr. Jos&#xe9; Penna, Bah&#xed;a Blanca, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lucarelli</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Servicio de Nefrolog&#xed;a Infantil, Hospital Interzonal General Dr. Jos&#xe9; Penna, Bah&#xed;a Blanca, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Arch Soc Esp Oftalmol (Engl Ed)</MedlineTA><NlmUniqueID>101715860</NlmUniqueID><ISSNLinking>2173-5794</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007166">Immunosuppressive Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008181" MajorTopicYN="Y">Lupus Nephritis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012173" MajorTopicYN="Y">Retinitis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002825" MajorTopicYN="Y">Chorioretinitis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007166" MajorTopicYN="N">Immunosuppressive Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Compromiso ocular</Keyword><Keyword MajorTopicYN="N">Eye involvement</Keyword><Keyword MajorTopicYN="N">Lupus eritematoso sist&#xe9;mico</Keyword><Keyword MajorTopicYN="N">Lupus nephritis</Keyword><Keyword MajorTopicYN="N">Nefritis l&#xfa;pica</Keyword><Keyword MajorTopicYN="N">Nephrotic syndrome</Keyword><Keyword MajorTopicYN="N">Neuroretinitis</Keyword><Keyword MajorTopicYN="N">Neurorretinitis</Keyword><Keyword MajorTopicYN="N">Systemic lupus erythematosus</Keyword><Keyword MajorTopicYN="N">S&#xed;ndrome nefr&#xf3;tico</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>4</Day><Hour>19</Hour><Minute>25</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36738922</ArticleId><ArticleId IdType="doi">10.1016/j.oftale.2023.01.002</ArticleId><ArticleId IdType="pii">S2173-5794(23)00009-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>